Michelle Long | Profiles RNS

Michelle T. Long, MD, MSc

Associate Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Preventive Medicine & Epidemiology

MD, Tufts University School of Medicine
MSc, Boston University School of Public Health
BA, Middlebury College

Pronouns: she/her/hers

Websites

	Boston Medical Center Provider Profile
	ResearchGate

ORCID : 0000-0001-6131-3981

Michelle T. Long, MD, MSc is a physician-scientist with an expertise in Nonalcoholic fatty liver disease (NAFLD), and an Associate Professor of Medicine at Boston University. She completed her clinical training at Massachusetts General Hospital and Boston Medical Center. Dr. Long is the Director of the NAFLD Research Center and the Director of Clinical Research for the Section of Gastroenterology and Hepatology. Her clinical and research interests center on the relationship between NAFLD and cardiovascular disease. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD and in imaging and risk stratification strategies for hepatic fibrosis. Dr. Long has projects at Boston Medical Center and at the Framingham Heart Study where she is the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. In Framingham, she is investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. Dr. Long receives research funding from the NIH (NIDDK), Doris Duke Charitable Foundation, Gilead Sciences, Echosens Corporation, and Boston University. She has expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. Dr. Long is also a clinical hepatologist and endoscopist.

Dr. Long is additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and runs the clinical trials program for the NAFLD Research Center.

Her other research interests include alcohol-related liver disease, hepatitis C, outcomes in end-stage liver disease/cirrhosis.

Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Gastroenterology

Investigator
Framingham Heart Study

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

Full Member
Boston University Medical Center
Boston Nutrition Obesity Research Center

Resting metabolic signature of non-alcoholic fatty liver disease and the metabolic response to acute exercise in a community based sample
07/01/2019 - 08/05/2022 (PI)
Doris Duke Charitable Foundation

Prevalence and risk factors for hepatic steatosis and fibrosis as measured by transient elastography
03/15/2016 - 05/31/2019 (PI)
Echosens

NATiV3: A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosis 3 (F3) stage
05/17/2022 - 05/17/2029 (PI)
Inventiva S.A.

ESSENCE: The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis-NN9931-4553
11/05/2021 - 11/05/2026 (PI)
Novo Nordisk

A Phase 1, Double Blind, Randomised, Placebo-controlled, Multi-centre, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2693 in Patients with Non-alcoholic Steatohepatitis (NASH) with Fibrosis S
12/01/2021 - 12/01/2024 (PI)
Astrazeneca Pharmaceuticals

Global Longitudinal Assessment of Nonalcoholic Fatty Liver Disease (NAFLD) using Magnetic Resonance Elastography GOLD-MINE Study Protocol
06/15/2020 - 06/14/2024 (PI)
The Regents of the University of Calif., U.C. San Diego Astrazeneca Pharmace

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating …
05/16/2017 - 05/31/2024 (PI)
Intercept Pharmaceuticals, Inc.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2a Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Orally Administered TERN-101 Tablets in Adult Patients with Presumed Non-Cirrhotic
09/08/2020 - 07/31/2023 (PI)
Terns Pharmaceuticals, Inc.

AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
07/01/2019 - 07/31/2023 (PI)
Allergan Sales, LLC

MB130-068
12/06/2018 - 03/31/2023 (PI)
Bristol-Myers Squibb Company

Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis
01/15/2020 - 01/14/2023 (PI)
Celgene

Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the…
01/12/2018 - 08/05/2022 (PI)
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
5K23DK113252-03

Showing 10 of 13 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs
2022	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-05
2021	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-04	15
2020	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-03	15
2019	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-02	15
2018	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	1K23DK113252-01A1	15

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Alanaeme CJ, Ghazi L, Akinyelure OP, Wen Y, Christenson A, Poudel B, Dooley EE, Chen L, Hardy ST, Foti K, Bowling CB, Long MT, Colantonio LD, Muntner P. Trends in the prevalence of multiple chronic conditions among US adults with hypertension from 1999-2000 through 2017-2020. Am J Hypertens. 2024 Apr 05. PMID: 38576398

Fantasia KL, Austad K, Mohanty A, Long MT, Walkey A, Drainoni ML. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation. Endocr Pract. 2024 Mar; 30(3):270-277.View Related Profiles.

Walkey, Allan
Mohanty, Arpan
Fantasia, Kathryn
Austad, Kirsten
Drainoni, Mari-Lynn
Long, Michelle

PMID: 38184239

Altajar S, Wang N, Rosenthaler MP, Murabito JM, Long MT. NAFLD Associates with Sarcopenia Defined by Muscle Mass and Slow Walking Speed: A Cross-Sectional Analysis from the Framingham Heart Study. J Clin Med. 2023 Dec 06; 12(24).View Related Profiles.

Murabito, Joanne
Long, Michelle

PMID: 38137592; PMCID: PMC10743412; DOI: 10.3390/jcm12247523;

Donovan K, Thomas OW, Sweeney T, Ryan TJ, Kytomaa S, Zhao M, Zhong W, Long M, Rajendran I, Sarfaty S, Lenders C. Eat to Treat: The Methods and Assessments of a Culinary Medicine Seminar for Future Physicians and Practicing Clinicians. Nutrients. 2023 Nov 17; 15(22).View Related Profiles.

Lenders, Carine
Long, Michelle
Sarfaty, Suzanne

PMID: 38004212; PMCID: PMC10674360; DOI: 10.3390/nu15224819;

Dichtel LE, Corey KE, Haines MS, Chicote ML, Lee H, Kimball A, Colling C, Simon TG, Long MT, Husseini J, Bredella MA, Miller KK. Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial. J Clin Endocrinol Metab. 2023 Nov 17; 108(12):e1542-e1550. PMID: 37379033; PMCID: PMC10655511; DOI: 10.1210/clinem/dgad375;

Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TL, Vilar-Gomez E, Wong VW, Schmitz KH. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023 Sep 01; 55(9):1717-1726. PMID: 37126039; PMCID: PMC10524517; DOI: 10.1249/MSS.0000000000003199;

Weinstein G, O'Donnell A, Frenzel S, Xiao T, Yaqub A, Yilmaz P, de Knegt RJ, Maestre GE, Melo van Lent D, Long M, Gireud-Goss M, Ittermann T, Frost F, Bülow R, Vasan RS, Grabe HJ, Ikram MA, Beiser AS, Seshadri S. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross-Cohort Collaboration. Eur J Neurol. 2024 Jan; 31(1):e16048.View Related Profiles.

Beiser, Alexa
Weinstein, Galit
Long, Michelle
Seshadri, Sudha

PMID: 37641505; PMCID: PMC10840827; DOI: 10.1111/ene.16048;

Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, Lin AE, McConkey ME, Vromman A, Sellar RS, Kim PG, Agrawal M, Weinstock J, Long MT, Yu B, Banerjee R, Nicholls RC, Dennis A, Kelly M, Loh PR, McCarroll S, Boerwinkle E, Vasan RS, Jaiswal S, Johnson AD, Chung RT, Corey K, Levy D, Ballantyne C, Ebert BL, Natarajan P. Author Correction: Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023 Jul; 619(7970):E47. PMID: 37400552

Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, Lin AE, McConkey ME, Vromman A, Sellar RS, Kim PG, Agrawal M, Weinstock J, Long MT, Yu B, Banerjee R, Nicholls RC, Dennis A, Kelly M, Loh PR, McCarroll S, Boerwinkle E, Vasan RS, Jaiswal S, Johnson AD, Chung RT, Corey K, Levy D, Ballantyne C, Ebert BL, Natarajan P. Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023 Apr; 616(7958):747-754. PMID: 37046084; PMCID: PMC10405350; DOI: 10.1038/s41586-023-05857-4;

Gao V, Long MT, Singh SR, Kim Y, Zhang X, Rogers G, Jacques PF, Levy D, Ma J. A Healthy Diet is Associated with a Lower Risk of Hepatic Fibrosis. J Nutr. 2023 May; 153(5):1587-1596. PMID: 37023964; PMCID: PMC10273161; DOI: 10.1016/j.tjnut.2023.03.038;

Showing 10 of 90 results. Show More

Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TG, Vilar-Gomez E, Wong VW, Schmitz KH. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatol Commun. 2023 Apr 01; 7(4). PMID: 36995998; PMCID: PMC10069861; DOI: 10.1097/HC9.0000000000000108;

Ahmed HS, Long MT. Reply: The associations between hepatic steatosis and incident cardiovascular disease and all-cause mortality. Hepatology. 2023 Jul 01; 78(1):E6-E7.View Related Profiles.

Ahmed, Heidi
Long, Michelle

PMID: 36932718

Ajmera V, Wang N, Xu H, Liu CT, Long MT. Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis. Aliment Pharmacol Ther. 2023 May; 57(10):1143-1150.View Related Profiles.

Liu, Ching-Ti
Long, Michelle

PMID: 36924053; PMCID: PMC10178778; DOI: 10.1111/apt.17452;

Sun DQ, Targher G, Byrne CD, Wheeler DC, Wong VW, Fan JG, Tilg H, Yuan WJ, Wanner C, Gao X, Long MT, Kanbay M, Nguyen MH, Navaneethan SD, Yilmaz Y, Huang Y, Gani RA, Marzuillo P, Boursier J, Zhang H, Jung CY, Chai J, Valenti L, Papatheodoridis G, Musso G, Wong YJ, El-Kassas M, Méndez-Sánchez N, Sookoian S, Pavlides M, Duseja A, Holleboom AG, Shi J, Chan WK, Fouad Y, Yang J, Treeprasertsuk S, Cortez-Pinto H, Hamaguchi M, Romero-Gomez M, Al Mahtab M, Ocama P, Nakajima A, Dai C, Eslam M, Wei L, George J, Zheng MH. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surg Nutr. 2023 Jun 01; 12(3):386-403. PMID: 37351121; PMCID: PMC10282675; DOI: 10.21037/hbsn-22-421;

Ahmed HS, Wang N, Carr JJ, Ding J, Terry JG, VanWagner LB, Hou L, Huo Y, Palmisano J, Zheng Y, Benjamin EJ, Long MT. The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort study. Hepatology. 2023 Jun 01; 77(6):2063-2072.View Related Profiles.

Benjamin, Emelia
Ahmed, Heidi
Long, Michelle

PMID: 36651168

Xu X, Alanaeme J, Wen Y, Colantonio LD, Muntner P, Long MT. Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population. Gastroenterology. 2023 Apr; 164(4):688-689.e4.View Related Profiles.

Long, Michelle
Xu, Xixi

PMID: 36623777; PMCID: PMC10038885; DOI: 10.1053/j.gastro.2023.01.001;

Rice BA, Naimi TS, Long MT. Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study. Clin Gastroenterol Hepatol. 2023 Oct; 21(11):2854-2863.e2.View Related Profiles.

Rice, Brooke
Long, Michelle
Naimi, Timothy

PMID: 36503167; PMCID: PMC10247898; DOI: 10.1016/j.cgh.2022.10.039;

Long MT, Noureddin M, Lim JK. Reply. Gastroenterology. 2023 Mar; 164(3):503. PMID: 36379247

Ahmed HS, Gangasani N, Jayanna MB, Long MT, Sanchez A, Murali AR. The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study. J Clin Exp Hepatol. 2023; 13(2):233-240.View Related Profiles.

Ahmed, Heidi
Long, Michelle

PMID: 36950488; PMCID: PMC10025751; DOI: 10.1016/j.jceh.2022.11.005;

Ahmed, Heidi
Long, Michelle

PMID: 36950488; PMCID: PMC10025751; DOI: 10.1016/j.jceh.2022.11.005;

Claypool K, Long MT, Patel CJ. Reply. Clin Gastroenterol Hepatol. 2023 Jun; 21(6):1672-1673. PMID: 36087712

Dichtel LE, Corey KE, Haines MS, Chicote ML, Kimball A, Colling C, Simon TG, Long MT, Husseini J, Bredella MA, Miller KK. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity. J Clin Endocrinol Metab. 2022 Aug 18; 107(9):e3624-e3632. PMID: 35779256; PMCID: PMC9387707; DOI: 10.1210/clinem/dgac405;

Long MT. Alcohol Consumption and Nonalcoholic Steatohepatitis/ Nonalcoholic Fatty Liver Disease. Gastroenterol Hepatol (N Y). 2022 Aug; 18(8):491-493. PMID: 36397815; PMCID: PMC9666804

Long MT, Noureddin M, Lim JK. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Gastroenterology. 2022 Sep; 163(3):764-774.e1. PMID: 35842345; PMCID: PMC9398982; DOI: 10.1053/j.gastro.2022.06.023;

Kammerlander A, Lyass A, Mahoney TF, Taron J, Eslami P, Lu MT, Long MT, Vasan RS, Massaro JM, Hoffmann U. Standardized measurement of abdominal muscle by computed tomography: association with cardiometabolic risk in the Framingham Heart Study. Eur Radiol. 2022 Oct; 32(10):7068-7078.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 35779090; PMCID: PMC9474583; DOI: 10.1007/s00330-022-08934-w;

Claypool K, Long MT, Patel CJ. Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1950-1954.e1. PMID: 35671890; PMCID: PMC9722977; DOI: 10.1016/j.cgh.2022.05.021;

Vujkovic M, Ramdas S, Lorenz KM, Guo X, Darlay R, Cordell HJ, He J, Gindin Y, Chung C, Myers RP, Schneider CV, Park J, Lee KM, Serper M, Carr RM, Kaplan DE, Haas ME, MacLean MT, Witschey WR, Zhu X, Tcheandjieu C, Kember RL, Kranzler HR, Verma A, Giri A, Klarin DM, Sun YV, Huang J, Huffman JE, Townsend Creasy K, Hand NJ, Liu CT, Long MT, Yao J, Budoff M, Tan J, Li X, Lin HJ, Chen YI, Taylor KD, Chang RK, Krauss RM, Vilarinho S, Brancale J, Nielsen JB, Locke AE, Jones MB, Verweij N, Baras A, Reddy KR, Neuschwander-Tetri BA, Schwimmer JB, Sanyal AJ, Chalasani N, Ryan KA, Mitchell BD, Gill D, Wells AD, Manduchi E, Saiman Y, Mahmud N, Miller DR, Reaven PD, Phillips LS, Muralidhar S, DuVall SL, Lee JS, Assimes TL, Pyarajan S, Cho K, Edwards TL, Damrauer SM, Wilson PW, Gaziano JM, O'Donnell CJ, Khera AV, Grant SFA, Brown CD, Tsao PS, Saleheen D, Lotta LA, Bastarache L, Anstee QM, Daly AK, Meigs JB, Rotter JI, Lynch JA, Rader DJ, Voight BF, Chang KM. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat Genet. 2022 Jun; 54(6):761-771.View Related Profiles.

Liu, Ching-Ti
O'Donnell, Christopher
Gaziano, J. Michael
Long, Michelle

PMID: 35654975; PMCID: PMC10024253; DOI: 10.1038/s41588-022-01078-z;

Krittanawong C, Isath A, Rosenson RS, Khawaja M, Wang Z, Fogg SE, Virani SS, Qi L, Cao Y, Long MT, Tangney CC, Lavie CJ. Alcohol Consumption and Cardiovascular Health. Am J Med. 2022 Oct; 135(10):1213-1230.e3. PMID: 35580715; PMCID: PMC9529807; DOI: 10.1016/j.amjmed.2022.04.021;

Park WY, Yiannakou I, Petersen JM, Hoffmann U, Ma J, Long MT. Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study. Clin Gastroenterol Hepatol. 2022 Nov; 20(11):2524-2532.e2. PMID: 34752964; PMCID: PMC9236136; DOI: 10.1016/j.cgh.2021.11.001;

Mehta M, Louissaint J, Parikh NS, Long MT, Tapper EB. Cognitive Function, Sarcopenia, and Inflammation Are Strongly Associated with Frailty: A Framingham Cohort Study. Am J Med. 2021 12; 134(12):1530-1538. PMID: 34464599; PMCID: PMC9004665; DOI: 10.1016/j.amjmed.2021.07.012;

Lau ES, Paniagua SM, Zarbafian S, Hoffman U, Long MT, Hwang SJ, Courchesne P, Yao C, Ma J, Larson MG, Levy D, Shah RV, Ho JE. Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction. J Am Heart Assoc. 2021 07 20; 10(14):e020215.View Related Profiles.

Larson, Martin
Long, Michelle
Hwang, Shih-Jen

PMID: 34219465; PMCID: PMC8483498; DOI: 10.1161/JAHA.120.020215;

Chua SG, Wasan SK, Long MT. How to Promote Career Advancement and Gender Equity for Women in Gastroenterology: A Multifaceted Approach. Gastroenterology. 2021 09; 161(3):792-797.View Related Profiles.

Long, Michelle
Wasan, Sharmeel

PMID: 34175283; PMCID: PMC8403503; DOI: 10.1053/j.gastro.2021.06.057;

Hagström H, Adams LA, Allen AM, Byrne CD, Chang Y, Grønbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J, Lazarus JV, Long MT, Loomba R, Newsome PN, Rowe IA, Ryu S, Schattenberg JM, Serper M, Sheron N, Simon TG, Tapper EB, Wild S, Wong VW, Yilmaz Y, Zelber-Sagi S, Åberg F. Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology. 2021 07; 74(1):474-482. PMID: 33486773; PMCID: PMC8515502; DOI: 10.1002/hep.31726;

Trivedi HD, Wilechansky R, Goyes D, Vieira Barbosa J, Canakis A, Lai M, Long MT, Fricker Z. Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19. Gastroenterology Res. 2021 Jun; 14(3):179-183.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 34267833; PMCID: PMC8256898; DOI: 10.14740/gr1389;

Kammerlander AA, Lyass A, Mahoney TF, Massaro JM, Long MT, Vasan RS, Hoffmann U. Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study. J Am Heart Assoc. 2021 06; 10(11):e019968.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 33998254; PMCID: PMC8483556; DOI: 10.1161/JAHA.120.019968;

Subramaniam M, Azad N, Wasan SK, Long MT. Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals. Am J Gastroenterol. 2021 03 01; 116(3):613-616.View Related Profiles.

Long, Michelle
Subramaniam, Mythri
Azad, Nabila
Wasan, Sharmeel

PMID: 33657045; PMCID: PMC8099049; DOI: 10.14309/ajg.0000000000001183;

Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJ. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology. 2021 02; 73(2):548-559.View Related Profiles.

Liu, Ching-Ti
Benjamin, Emelia
Long, Michelle

PMID: 33125745; PMCID: PMC8515503; DOI: 10.1002/hep.31608;

Li BT, Simon TG, Wang N, Chung RT, Corey KE, Dichtel LE, Samelson EJ, Kiel DP, Long MT. Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community-Based Cohort. Obesity (Silver Spring). 2021 03; 29(3):595-600. PMID: 33528915; PMCID: PMC7904629; DOI: 10.1002/oby.23100;

Zhang X, Xu H, Li GH, Long MT, Cheung CL, Vasan RS, Hsu YH, Kiel DP, Liu CT. Metabolomics Insights into Osteoporosis Through Association With Bone Mineral Density. J Bone Miner Res. 2021 04; 36(4):729-738.View Related Profiles.

Liu, Ching-Ti
Long, Michelle

PMID: 33434288; PMCID: PMC8488880; DOI: 10.1002/jbmr.4240;

Mohanty A, Eshein A, Kamineni P, Avissar U, Bliss CM, Long MT, Lowe RC, Moore TC, Nunes DP, Backman V, Roy HK. Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept study. Gastrointest Endosc. 2021 07; 94(1):60-67.e1.View Related Profiles.

Mohanty, Arpan
Bliss, Charles
Nunes, David
Roy, Hemant
Long, Michelle
Lowe, Robert
Avissar, Uri

PMID: 33385462; PMCID: PMC8546777; DOI: 10.1016/j.gie.2020.12.037;

Long MT, Naimi TS. Reply. Clin Gastroenterol Hepatol. 2021 07; 19(7):1506-1507.View Related Profiles.

Long, Michelle
Naimi, Timothy

PMID: 33248106

DeCoste LR, Wang N, Palmisano JN, Mendez J, Hoffmann U, Benjamin EJ, Long MT. Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis. Hepatol Commun. 2021 Jan; 5(1):74-82.View Related Profiles.

Benjamin, Emelia
Long, Michelle

PMID: 33437902; PMCID: PMC7789839; DOI: 10.1002/hep4.1614;

Bianco C, Romeo S, Petta S, Long MT, Valenti L. MAFLD vs NAFLD: Let the contest begin! Liver Int. 2020 09; 40(9):2079-2081. PMID: 32930521; PMCID: PMC7510483; DOI: 10.1111/liv.14620;

Chiu LS, Pedley A, Massaro JM, Benjamin EJ, Mitchell GF, McManus DD, Aragam J, Vasan RS, Cheng S, Long MT. The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. Liver Int. 2020 10; 40(10):2445-2454.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Chiu, Laura
Long, Michelle

PMID: 32654390; PMCID: PMC7669676; DOI: 10.1111/liv.14600;

Long MT, Gandhi S, Loomba R. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism. 2020 10; 111S:154259. PMID: 32387227; PMCID: PMC7529729; DOI: 10.1016/j.metabol.2020.154259;

Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing liver fat is associated with progression of cardiovascular risk factors. Liver Int. 2020 06; 40(6):1339-1343.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 32301571; PMCID: PMC8414370; DOI: 10.1111/liv.14472;

Fricker ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, Attar BM, Balakrishnan M, Ghabril M, Long MT. MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis. Dig Dis Sci. 2021 01; 66(1):247-256.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 32100160; PMCID: PMC7222109; DOI: 10.1007/s10620-020-06164-y;

So-Armah KA, Lim JK, Lo Re V, Tate JP, Chang CH, Butt AA, Gibert CL, Rimland D, Marconi VC, Goetz MB, Ramachandran V, Brittain E, Long M, Nguyen KL, Rodriguez-Barradas MC, Budoff MJ, Tindle HA, Samet JH, Justice AC, Freiberg MS. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):184-191.View Related Profiles.

Samet, Jeffrey
So-Armah, Kaku
Long, Michelle
Ramachandran, Vasan

PMID: 32068085; PMCID: PMC7278895; DOI: 10.1016/j.pcad.2020.02.010;

Long MT, Naimi TS. Reply. Clin Gastroenterol Hepatol. 2020 06; 18(7):1651-1652.View Related Profiles.

Long, Michelle
Naimi, Timothy

PMID: 31926338; PMCID: PMC8631247; DOI: 10.1016/j.cgh.2020.01.001;

Long MT, Massaro JM, Hoffmann U, Benjamin EJ, Naimi TS. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2020 07; 18(8):1831-1841.e5.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Naimi, Timothy

PMID: 31734449; PMCID: PMC7569606; DOI: 10.1016/j.cgh.2019.11.022;

Soni K, Fricker Z, Long MT. Pyogenic liver abscesses from Fusobacterium nucleatum in an immunocompetent host. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):e59-e60.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 31607642; PMCID: PMC7145721; DOI: 10.1016/j.clinre.2019.09.001;

Brunner KT, Henneberg CJ, Wilechansky RM, Long MT. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Curr Obes Rep. 2019 Sep; 8(3):220-228.View Related Profiles.

Long, Michelle
Wilechansky, Robert

PMID: 30945129; PMCID: PMC6770992; DOI: 10.1007/s13679-019-00345-1;

Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. Clin Gastroenterol Hepatol. 2020 07; 18(8):1884-1886.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 31404666; PMCID: PMC7007830; DOI: 10.1016/j.cgh.2019.08.003;

Chen VL, Wright AP, Halligan B, Chen Y, Du X, Handelman SK, Long MT, Kiel DP, Speliotes EK. Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Hepatol Commun. 2019 Aug; 3(8):1073-1084. PMID: 31388628; PMCID: PMC6671828; DOI: 10.1002/hep4.1391;

Wilechansky RM, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver Int. 2019 08; 39(8):1535-1544.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Wilechansky, Robert

PMID: 31033142; PMCID: PMC6675651; DOI: 10.1111/liv.14125;

Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038.View Related Profiles.

Nunes, David
Farraye, Francis
Long, Michelle

PMID: 30945037; PMCID: PMC6764090; DOI: 10.1007/s10620-019-05595-6;

Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Therap Adv Gastroenterol. 2019; 12:1756284819832237.View Related Profiles.

Ko, Darae
Benjamin, Emelia
Sherer, Jason
Arnold, Lindsay
Trinquart, Ludovic
Long, Michelle
Helm, Robert

PMID: 30984290; PMCID: PMC6448121; DOI: 10.1177/1756284819832237;

Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds LM, Ghanbari M, Muka T, van Meurs JBJ, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SLR, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Darwish Murad S, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. Diabetes. 2019 05; 68(5):1073-1083.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30936141; PMCID: PMC6477898; DOI: 10.2337/DB18-1193;

Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One. 2019; 14(3):e0211811.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 30840670; PMCID: PMC6402644; DOI: 10.1371/journal.pone.0211811;

Hennein R, Liu C, McKeown NM, Hoffmann U, Long MT, Levy D, Ma J. Increased Diet Quality is Associated with Long-Term Reduction of Abdominal and Pericardial Fat. Obesity (Silver Spring). 2019 04; 27(4):670-677.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30825267; PMCID: PMC6430652; DOI: 10.1002/oby.22427;

Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds L, Ghanbari M, Muka T, van Meurs J, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SL, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Murad SD, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver Disease. Diabetes. 2019 Feb 22.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30796027

Simon TG, Deng X, Liu CT, Chung RT, Long MT. The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study. Liver Int. 2019 06; 39(6):1022-1026.View Related Profiles.

Liu, Ching-Ti
Long, Michelle

PMID: 30597691; PMCID: PMC6535115; DOI: 10.1111/liv.14039;

Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. Clin Gastroenterol Hepatol. 2019 05; 17(6):1157-1164.e4.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Fricker, Zachary

PMID: 30476583; PMCID: PMC6475462; DOI: 10.1016/j.cgh.2018.11.037;

Long MT, Gurary EB, Massaro JM, Ma J, Hoffmann U, Chung RT, Benjamin EJ, Loomba R. Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring. Liver Int. 2019 04; 39(4):740-747.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 30179294; PMCID: PMC6758911; DOI: 10.1111/liv.13956;

Tran AN, Sachdev R, Fricker ZP, Leber M, Zahorian T, Shah B, Nunes DP, Long MT. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital. Dig Dis Sci. 2018 12; 63(12):3241-3249.View Related Profiles.

Nunes, David
Long, Michelle
Fricker, Zachary

PMID: 30078116; PMCID: PMC6770976; DOI: 10.1007/s10620-018-5231-0;

Ma J, Hennein R, Liu C, Long MT, Hoffmann U, Jacques PF, Lichtenstein AH, Hu FB, Levy D. Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 07; 155(1):107-117.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 29604292; PMCID: PMC6035111; DOI: 10.1053/j.gastro.2018.03.038;

Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, Chung RT, Benjamin EJ. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. Liver Int. 2018 08; 38(8):1495-1503.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 29377504; PMCID: PMC6206437; DOI: 10.1111/liv.13709;

Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study. Am J Med. 2018 06; 131(6):684-692.e12.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 29518370; PMCID: PMC5964004; DOI: 10.1016/j.amjmed.2018.02.002;

Long MT, Benjamin EJ. Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis. Circ Cardiovasc Imaging. 2018 03; 11(3):e007553.View Related Profiles.

Benjamin, Emelia
Long, Michelle

PMID: 29523556; PMCID: PMC5846198; DOI: 10.1161/CIRCIMAGING.118.007553;

Datta S, Sherva RM, De La Cruz M, Long MT, Roy P, Backman V, Chowdhury S, Roy HK. Single Nucleotide Polymorphism Facilitated Down-Regulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities. Neoplasia. 2018 03; 20(3):289-294.View Related Profiles.

Roy, Hemant
Long, Michelle
Sherva, Richard
Chowdhury, Sanjib
Datta, Somenath

PMID: 29471289; PMCID: PMC5883624; DOI: 10.1016/j.neo.2018.01.003;

Shah RV, Yeri AS, Murthy VL, Massaro JM, D'Agostino R, Freedman JE, Long MT, Fox CS, Das S, Benjamin EJ, Vasan RS, O'Donnell CJ, Hoffmann U. Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study. JAMA Cardiol. 2017 11 01; 2(11):1236-1246.View Related Profiles.

O'Donnell, Christopher
Benjamin, Emelia
Long, Michelle
D'Agostino, Ralph
Ramachandran, Vasan

PMID: 28975197; PMCID: PMC5710362; DOI: 10.1001/jamacardio.2017.3145;

O'Sullivan JF, Morningstar JE, Yang Q, Zheng B, Gao Y, Jeanfavre S, Scott J, Fernandez C, Zheng H, O'Connor S, Cohen P, Vasan RS, Long MT, Wilson JG, Melander O, Wang TJ, Fox C, Peterson RT, Clish CB, Corey KE, Gerszten RE. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest. 2017 12 01; 127(12):4394-4402.View Related Profiles.

Long, Michelle
Yang, Qiong
Ramachandran, Vasan

PMID: 29083323; PMCID: PMC5707166; DOI: 10.1172/JCI95995;

Lee JJ, Pedley A, Hoffmann U, Massaro JM, O'Donnell CJ, Benjamin EJ, Long MT. Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study). Am J Cardiol. 2018 01 15; 121(2):162-167.View Related Profiles.

O'Donnell, Christopher
Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 29146023; PMCID: PMC5742312; DOI: 10.1016/j.amjcard.2017.10.006;

Li W, Dorans KS, Wilker EH, Rice MB, Long MT, Schwartz J, Coull BA, Koutrakis P, Gold DR, Fox CS, Mittleman MA. Residential Proximity to Major Roadways, Fine Particulate Matter, and Hepatic Steatosis: The Framingham Heart Study. Am J Epidemiol. 2017 Oct 01; 186(7):857-865. PMID: 28605427; PMCID: PMC5860476; DOI: 10.1093/aje/kwx127;

Kimberly WT, O'Sullivan JF, Nath AK, Keyes M, Shi X, Larson MG, Yang Q, Long MT, Vasan R, Peterson RT, Wang TJ, Corey KE, Gerszten RE. Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight. 2017 May 04; 2(9).View Related Profiles.

Larson, Martin
Long, Michelle
Yang, Qiong

PMID: 28469090; PMCID: PMC5414569; DOI: 10.1172/jci.insight.92989;

Long MT, Yin X, Larson MG, Ellinor PT, Lubitz SA, McManus DD, Magnani JW, Staerk L, Ko D, Helm RH, Hoffmann U, Chung RT, Benjamin EJ. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc. 2017 May 02; 6(5).View Related Profiles.

Ko, Darae
Benjamin, Emelia
Larson, Martin
Long, Michelle
Helm, Robert

PMID: 28465298; PMCID: PMC5524082; DOI: 10.1161/JAHA.116.005227;

Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, Long MT. Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. Am J Med. 2017 Aug; 130(8):958-966.e1.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 28238696; PMCID: PMC5522762; DOI: 10.1016/j.amjmed.2017.01.044;

Shao D, Han J, Hou X, Fry J, Behring JB, Seta F, Long MT, Roy HK, Cohen RA, Matsui R, Bachschmid MM. Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. Antioxid Redox Signal. 2017 Aug 20; 27(6):313-327.View Related Profiles.

Shao, Di
Seta, Francesca
Roy, Hemant
Behring, Jessica
Fry, Jessica
Han, Jingyan
Bachschmid, Markus
Long, Michelle
Matsui, Reiko
Cohen, Richard

PMID: 27958883; PMCID: PMC5563925; DOI: 10.1089/ars.2016.6716;

Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, Benjamin EJ, Levy D, Fox CS, Long MT. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017 Feb; 66(2):390-397.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Hwang, Shih-Jen

PMID: 27729222; PMCID: PMC5250546; DOI: 10.1016/j.jhep.2016.09.022;

Ko D, Riles EM, Marcos EG, Magnani JW, Lubitz SA, Lin H, Long MT, Schnabel RB, McManus DD, Ellinor PT, Ramachandran VS, Wang TJ, Gerszten RE, Benjamin EJ, Yin X, Rienstra M. Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol. 2016 Nov 15; 118(10):1493-1496.View Related Profiles.

Ko, Darae
Benjamin, Emelia
Lin, Honghuang
Long, Michelle
Ramachandran, Vasan

PMID: 27666170; PMCID: PMC5097881; DOI: 10.1016/j.amjcard.2016.08.010;

Cui J, Chen CH, Lo MT, Schork N, Bettencourt R, Gonzalez MP, Bhatt A, Hooker J, Shaffer K, Nelson KE, Long MT, Brenner DA, Sirlin CB, Loomba R, For The Genetics Of Nafld In Twins Consortium. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology. 2016 Nov; 64(5):1547-1558. PMID: 27315352; PMCID: PMC5090982; DOI: 10.1002/hep.28674;

Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study. PLoS One. 2016; 11(6):e0157517.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 27341207; PMCID: PMC4920364; DOI: 10.1371/journal.pone.0157517;

Long MT, Pedley A, Colantonio LD, Massaro JM, Hoffmann U, Muntner P, Fox CS. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis. Clin Gastroenterol Hepatol. 2016 Aug; 14(8):1172-1180.e2.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 27046482; PMCID: PMC4955680; DOI: 10.1016/j.cgh.2016.03.034;

Long MT, Fox CS. The Framingham Heart Study--67 years of discovery in metabolic disease. Nat Rev Endocrinol. 2016 Mar; 12(3):177-83. PMID: 26775764; DOI: 10.1038/nrendo.2015.226;

Long MT, Pedley A, Massaro JM, Hoffmann U, Esliger DW, Vasan RS, Fox CS, Murabito JM. Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry. Obesity (Silver Spring). 2015 Jun; 23(6):1259-66.View Related Profiles.

Murabito, Joanne
Massaro, Joseph
Long, Michelle
Ramachandran, Vasan

PMID: 25959049; PMCID: PMC4446168; DOI: 10.1002/oby.21058;

Long MT, Leszczynski A, Thompson KD, Wasan SK, Calderwood AH. Female authorship in major academic gastroenterology journals: a look over 20 years. Gastrointest Endosc. 2015; 81(6):1440-1447.e3.View Related Profiles.

Calderwood, Audrey
Long, Michelle
Wasan, Sharmeel

PMID: 25887727; DOI: 10.1016/j.gie.2015.01.032;

Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, Hoffmann U, Speliotes EK, Vita JA, Benjamin EJ, Fox CS, Hamburg NM. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol. 2015 May; 35(5):1284-91.View Related Profiles.

Benjamin, Emelia
Vita, Joseph
Larson, Martin
Long, Michelle
Hamburg, Naomi
Ramachandran, Vasan

PMID: 25745056; PMCID: PMC4520415; DOI: 10.1161/ATVBAHA.114.305200;

Long M, Lichtenstein D. Review: in high-risk ulcers, intermittent and continuous PPI therapy do not differ for recurrent bleeding. Ann Intern Med. 2015 Jan 20; 162(2):JC8.View Related Profiles.

Lichtenstein, David
Long, Michelle

PMID: 25599368; DOI: 10.7326/ACPJC-2015-162-2-008;

Rosenquist KJ, Massaro JM, Pedley A, Long MT, Kreger BE, Vasan RS, Murabito JM, Hoffmann U, Fox CS. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab. 2015 Jan; 100(1):227-34.View Related Profiles.

Kreger, Bernard
Murabito, Joanne
Massaro, Joseph
Long, Michelle
Ramachandran, Vasan

PMID: 25226289; PMCID: PMC5399496; DOI: 10.1210/jc.2013-4296;

Mendel JB, Long M, Slanetz PJ. CT-guided core needle biopsy of breast lesions visible only on MRI. AJR Am J Roentgenol. 2007 Jul; 189(1):152-4.View Related Profiles.

Long, Michelle
Slanetz, Priscilla

PMID: 17579165

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 89 publications over 11 distinct years, with a maximum of 14 publications in 2023

Bar chart showing 89 publications over 11 distinct years, with a maximum of 14 publications in 2023

Year	Publications
2007	1
2015	5
2016	6
2017	8
2018	8
2019	13
2020	10
2021	11
2022	11
2023	14
2024	2

Tweets by drmtlong

Twitter likes by drmtlong

Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?

Hep 8/4/2023

Even Non-heavy Drinking May Lead to Liver Problems, Says New Study

Eat this, not that 12/20/2022

Study finds non-heavy alcohol use associated with liver fibrosis

Medical Xpress 12/8/2022

Not the Usual Suspects: Don't Overlook NAFLD in Lean Patients

Medscape 8/30/2022

New Update Focuses on NAFLD in Lean People

Medscape 7/26/2022

New update focuses on NAFLD in lean people

MDedge 7/26/2022

Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis

MedPage Today 6/27/2022

Fatigue Tied to Worse Outcomes in Patients With NASH

MedPage Today 5/9/2022

Adding Mesalamine to Corticosteroids Showed No Benefit in Patients With Severe UC

Medpage Today 4/13/2022

Study Supports Expanded Use of HCV-Infected Liver Donation

Medpage Today 4/11/2022

Review Highlights Unmet Need for More Effective Therapies in Crohn's

Medpage Today 3/16/2022

Drinking These Popular Beverages More Than Doubles Your Risk for Fatty Liver Disease

Woman's World 11/30/2021

The #1 Worst Drink for Your Liver, New Study Says

Eat This, Not That! 11/14/2021

Pan-PPAR Agonist 'Promising' for NASH Patients

MedPage Today 10/20/2021

9 Actionable Ways to Support Gender Equity in Gastroenterology

HealthCity 9/29/2021

Removing Opioids From the PASS Will Be Beneficial

Medpage Today 9/27/2021

Herbal Weight-Loss Supplement Tied to Severe Liver Damage

MedPage Today 8/17/2021

Medical Campus Promotes 13 Faculty to Associate Professor

BU Today 7/30/2021

FAST Score Can Stratify NASH Risk in Diabetics

Gastroenterology & Endoscopy News 5/25/2021

Boston Medical Center Receives Support from Gilead Sciences to Improve Care for High-Risk Patients Living with Non-Alcoholic Fatty Liver Disease

Mobile Health Times 1/12/2021

Obese Patients With NAFLD May Have Lower Cirrhosis Risk After Bariatric Surgery

Medscape 4/13/2020

Obese Patients with NAFLD May Have Lower Cirrhosis Risk after Bariatric Surgery

MD Alert 4/11/2020

NAFLD Fibrosis Confirmed to Predict Poor Outcome

MedPage Today 2/7/2020

Alcohol Use Increases Risk for Clinically Defined NAFLD

Healio 12/11/2019

Concord Doctor Receives Doris Duke Clinical Scientist Development Award

Wicked Local Concord 7/22/2019

2020 Boston University School of Medicine: Resident Research Mentor Award

2019 NASH TAG Conference: Emerging Leader in NAFLD

2016 Boston University School of Medicine: Women's Leadership Conference Selected Participant

2016 Boston University School of Medicine: Faculty Development and Diversity Grant Recipient

2015-2020 Boston University School of Medicine: NIH Loan Repayment Program Recipient

2014 Boston University School of Medicine: 3rd Place, Evans Research Day

2009 Tufts University School of Medicine: Massachusetts Medical Society Scholars Award

2009 Tufts University School of Medicine: Glasgow-Rubin Citation for Academic Achievement

2009 Tufts University School of Medicine: Phi Delta Epsilon Fraternity Award

2009 Tufts University School of Medicine: Alpha Omega Alpha

2008 Tufts University School of Medicine: Magna cum laude Scientific electronic exhibit award

2008 Tufts University School of Medicine: Ada Draper, MD Scholarship

2006-2007 Tufts University School of Medicine: Boston Albert Schweitzer Fellowship

2006-2008 Tufts University School of Medicine: USA Funds Scholarship

2004 Middlebury College: Magna cum laude

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Cardiovascular Disease
Epidemiology
Fibrosis
Hepatology
Inflammation
Non-alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic Steatohepatitis (NASH)
Risk Stratification
Genetics, Human
Genomics
Metabolomics
Alcohol-Related Disorders

Dr. Long mentors Fellows, PhD Candidates, Residents, Medical Students and Undergraduate Students.

Available to Mentor as: (Review Mentor Role Definitions):

Advisor
Career Mentor
Co-Mentor or Peer Mentor
Diversity Mentor
Education Mentor
Project Mentor
Research / Scholarly Mentor
Work / Life Integration Mentor

Contact for Mentoring:

Email (see 'Contact Info')

85 E. Concord St
Boston MA 02118
Google Map

617.638.8392

Download vCard

Long's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (291) concept(s)

Media Mentions

Co-Authors

See all (53) people

Similar People

See all (60) people

Same Department

Search Department